Evidence map›Paper›PMID 34575141›Full record

ArticleLife (Basel, Switzerland)2021

The Procoagulant Activity of Emoxilane

Raffaella Belvedere, Nunzia Novizio, Daniela Eletto, Amalia Porta, Antonino Bagnulo, Andrea Cerciello, Umberto Di Maio, Antonello Petrella

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative.International journal of molecular sciences · 2023
    Article
  2. The Protecting Activity of RIPACUTLife (Basel, Switzerland) · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Raffaella BelvedereDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.ORCID 0000-0002-5036-7869
Nunzia NovizioDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.
Daniela ElettoDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.ORCID 0000-0001-6967-1812
Amalia PortaDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.ORCID 0000-0001-5947-9472
Antonino BagnuloNeilos Srl, Via Bagnulo 95, 80063 Piano di Sorrento, Italy.
Andrea CercielloNeilos Srl, Via Bagnulo 95, 80063 Piano di Sorrento, Italy.
Umberto Di MaioShedir Pharma Group Spa, Via Bagnulo 95, 80063 Piano di Sorrento, Italy.
Antonello PetrellaDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.ORCID 0000-0002-6945-5295
University of Salerno · IT

Funding

Shedir Pharma S.r.l Shedir Pharma srl
6 · The paper itself

Abstract

Epistaxis is one of the most frequent hemorrhages resulting from local or systemic factors. Its management without hospitalization has prompted an interest in locally applied hemostatic agents. Generally, the therapy approaches involve sprays or creams acting as a physical barrier, even used as tampons or gauze. In this study, we have investigated the activity of Emoxilane

Indexed as

antimicrobial effectsD-panthenolEmoxilane®epistaxisoxidationplasmin activitysilver nitratesodium hyaluronatethrombin levelsα-tocopherol

Identifiers

PMID34575141
PMCPMC8472423
OpenAlexW3198962445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.